Prothena Corp PlcPRTA
Price$8.54

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $54.5M-59.7% YoYTTM through 30 Jun 2026
Net Income -$44MTTM through 30 Jun 2026
Free Cash Flow -$60MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin-100.3%
Operating Margin58.8%
Net Margin-80.7%

Returns

-48.4%ROE
-43.2%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio10.43x
Net Debt-$329.5Mnet cash position
Cash & Equivalents$288.2M

Quality Metrics

Altman Z-Score12.17
Piotroski F-Score3 / 9
FCF Margin-110.1%
Rule of 40-57.3
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $9.7M
Diluted EPS-$0.82TTM
'19'20'21'22'23'24'25
FY2025: $-4.53

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.